Literature DB >> 15389565

Ectodomain shedding of membrane-anchored heparin-binding EGF like growth factor and subcellular localization of the C-terminal fragment in the cell cycle.

Fujio Toki1, Daisuke Nanba, Nariaki Matsuura, Shigeki Higashiyama.   

Abstract

Heparin-binding EGF-like growth factor (HB-EGF) is initially synthesized as a type I transmembrane protein (proHB-EGF). The proHB-EGF is shed by specific metalloproteases, releasing the N-terminal fragment into the extracellular space as a soluble growth factor (HB-EGF) and the C-terminal fragment (HB-EGF-C) into the intracellular space, where it prevents transcriptional repression by the promyelocytic leukemia zinc finger protein (PLZF). The goal of the present study was to characterize regulation of proHB-EGF shedding and study its temporal variations in HB-EGF-C localization throughout the cell cycle. Quantitative combination analyses of cell surface proHB-EGF and HB-EGF in conditioned medium showed that proHB-EGF shedding occurred during the G(1) cell cycle phase. Laser scanning cytometry (LSC) revealed that HB-EGF-C was internalized into the cytoplasm during the late G1 phase and accumulated in the nucleus beginning in the S phase. Subsequent nuclear export of PLZF occurred during the late S phase. Further, HB-EGF-C was localized around the centrosome following breakdown of the nuclear envelope and was localized to the interzonal space with chromosome segregation in the late M phase. Temporal variations in HB-EGF localization throughout the cell cycle were also characterized by time-lapse imaging of cells expressing YFP-tagged proHB-EGF, and these results were consistent with those obtained in cytometry studies. These results indicate that proHB-EGF shedding and subsequent HB-EGF-C signaling are related with progression of the cell cycle and may provide a clue to understand the unique biological significance of non-receptor-mediated signaling of proHB-EGF in cell growth. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15389565     DOI: 10.1002/jcp.20175

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

1.  A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans.

Authors:  Gerold Bongers; Luciana R Muniz; Michelle E Pacer; Alina C Iuga; Nanthakumar Thirunarayanan; Erik Slinger; Martine J Smit; E Premkumar Reddy; Lloyd Mayer; Glaucia C Furtado; Noam Harpaz; Sergio A Lira
Journal:  Gastroenterology       Date:  2012-05-26       Impact factor: 22.682

Review 2.  When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.

Authors:  David J DeGraff; Justin M Cates; Joshua R Mauney; Peter E Clark; Robert J Matusik; Rosalyn M Adam
Journal:  Urol Oncol       Date:  2011-09-15       Impact factor: 3.498

3.  Amino-terminal deletion of heparin-binding epidermal growth factor-like growth factor4-127 stimulates cell proliferation but lacks insulin-like activity.

Authors:  Z Zhou; P A Harding
Journal:  Cell Prolif       Date:  2007-04       Impact factor: 6.831

Review 4.  The role of protease activity in ErbB biology.

Authors:  Carl P Blobel; Graham Carpenter; Matthew Freeman
Journal:  Exp Cell Res       Date:  2008-10-25       Impact factor: 3.905

5.  miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma.

Authors:  Nadia Felli; Federica Felicetti; Anna Maria Lustri; M Cristina Errico; Lisabianca Bottero; Alessio Cannistraci; Alessandra De Feo; Marina Petrini; Francesca Pedini; Mauro Biffoni; Ester Alvino; Massimo Negrini; Manuela Ferracin; Gianfranco Mattia; Alessandra Carè
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

6.  Nuclear trafficking of secreted factors and cell-surface receptors: new pathways to regulate cell proliferation and differentiation, and involvement in cancers.

Authors:  Nathalie Planque
Journal:  Cell Commun Signal       Date:  2006-10-18       Impact factor: 5.712

7.  An Integrative Analysis of Preeclampsia Based on the Construction of an Extended Composite Network Featuring Protein-Protein Physical Interactions and Transcriptional Relationships.

Authors:  Daniel Vaiman; Francisco Miralles
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

8.  AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression.

Authors:  N Felli; M C Errico; F Pedini; M Petrini; R Puglisi; M Bellenghi; A Boe; F Felicetti; G Mattia; A De Feo; L Bottero; C Tripodo; A Carè
Journal:  Oncogene       Date:  2015-10-05       Impact factor: 9.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.